Stem cell researcher Jacob Hanna’s correction count updated to 10

Jacob Hanna
Jacob Hanna

Thanks to some eagle-eyed readers, we’ve been alerted to some corrections for high profile stem cell scientist Jacob Hanna that we had missed, bringing our count to one retraction and 13 errata on 10 papers.

The problems in the work range from duplications of images, to inadvertent deletions in figures, to failures by his co-authors to disclose funding sources or conflicts of interest. Hanna is the first or last author on 4 of the papers, and one of several on the rest.

First up, a correction to a Cell paper on which Hanna is the first author:

Continue reading Stem cell researcher Jacob Hanna’s correction count updated to 10

NSF investigation of high-profile plant retractions ends in two debarments

Jorge Vivanco
Jorge Vivanco

A nearly ten-year-long series of investigations into a pair of plant physiologists who received millions in funding from the U.S. National Science Foundation has resulted in debarments of less than two years for each of the researchers.

The NSF Office of Inspector General recently posted its close-out report on its decision and a review of the University’s investigation, which had recommended a total of eight retractions or corrections. Although the investigator’s names have been redacted, the text of retractions and corrections quoted in the report corresponds to papers by Continue reading NSF investigation of high-profile plant retractions ends in two debarments

Retraction of grizzly bear-diabetes study follows departure of Amgen scientist for data manipulation

cov150h
The retracted paper made the cover of the August 2014 issue of the journal.

A study that looked to hibernating bears to understand the mechanisms behind diabetes has been retracted because an author based at the biotech company Amgen “manipulated specific experimental data” in two figures.

According to the The Wall Street JournalAmgen discovered the manipulation while reviewing the data following publication of the paper,”Grizzly bears exhibit augmented insulin sensitivity while obese prior to a reversible insulin resistance during hibernation.” Published in Cell Metabolism last year, the paper has been cited 8 times, according to Thomson Scientific’s Web of Knowledge.

A press release from the journal last year — coverage in Science and Nature followed — explained the purpose of the study:

Continue reading Retraction of grizzly bear-diabetes study follows departure of Amgen scientist for data manipulation

Authors’ pharma ties cause Cochrane to withdraw two diabetes reviews

Cochrane_LogoThe Cochrane Library has withdrawn two reviews evaluating the effectiveness of diabetes treatments because some of the papers’ authors work with pharmaceutical companies.

Bianca Hemmingsen, first author on both reviews, told us the Cochrane Library asked the authors to remove the researchers with ties to pharma, but after one “refused to withdraw,” both papers were pulled entirely.

However, Hemmingsen insists that their employment had no impact on either paper.

This breaks the typical mold for Cochrane withdrawals, which are usually only pulled to indicate updates and show that older reviews no longer represent the best evidence.

Continue reading Authors’ pharma ties cause Cochrane to withdraw two diabetes reviews

Two groups mistakenly publish case reports on the same patient

Journal of Clinical Pharmacy and Therapeutics

Talk about a popular patient: A woman who developed a case of internal bleeding while taking the anticoagulant Xarelto (rivaroxaban) was written up in not one — but two — case reports. The trouble was, both groups didn’t realize what the other was doing, so the more recent article is now being retracted from the Journal of Clinical Pharmacy and Therapeutics.

The authors, a trio of doctors at Sakarya University in Turkey, described the case of a 75 year-old woman who came to the emergency room for fatigue and stomach pain after taking rivaroxaban for three days. A scan revealed a rectus sheath hematoma.

However, the case had already been published a few months earlier in the Indian Journal of Pharmacology by a separate group of doctors from Sakarya, along with authors from Yenikent State Hospital and Vakfikebir State Hospital.

Continue reading Two groups mistakenly publish case reports on the same patient

Updated: Author resigns from West Point following paper legitimizing attacks on scholars who question terror tactics

nilj_680x312

[Note: This post has been updated with new information about the author’s resignation.]

Following criticisms of a 2015 paper which proposed attacks on scholars who question the government’s handling of the war on terror, the author has resigned from his post at the U.S. Military Academy at West Point, New York.

The nearly 200-page paper, “Trahison des Professeurs: The Critical Law of Armed Conflict Academy as an Islamist Fifth Column,” appeared in the National Security Law Journal of George Mason University School of Law, in Virginia. It was written by William C. Bradford, who is a somewhat controversial figure.

In the paper, Bradford, assistant professor at the United States Military Academy, criticizes U.S. academics who specialize in armed conflict and claim “that the Islamist jihad is a response to valid grievances against U.S. foreign policy”: Continue reading Updated: Author resigns from West Point following paper legitimizing attacks on scholars who question terror tactics

Investigation of prominent geneticist Latchman finds “procedural matters,” no misconduct

David Latchman, Birkbeck

An investigation by the University College London has cleared prominent geneticist David Latchman of misconduct, but concluded he has “procedural matters in his lab that required attention.”

Latchman has two retracted paperson PubPeer, there are questions about nearly four dozen more.

The results of the investigation were first reported by the Times Higher Education. We also received a short statement from a UCL spokesperson:

Continue reading Investigation of prominent geneticist Latchman finds “procedural matters,” no misconduct

PubPeer founders reveal themselves, create foundation

pubpeer

The creators of PubPeer dropped their own anonymity today, as part of an announcement about a new chapter in the life of the post-publication peer review site.

By now, Retraction Watch readers will be familiar with PubPeer.com. Founded in 2012, the commenting site has allowed for robust discussions of scientific papers — which in turn have led to corrections and retractions. (We regularly feature discussions there in our PubPeer Selections feature.) The site has many supporters — including us — but also some critics, one of whom has filed suit against its commenters, arguing anonymous comments cost him a job opportunity. (Late last week, PubPeer learned that a judge had granted them the right to appeal the most recent decision in that case.)

Like most of the commenters on the site, whose careers could be threatened if they were exposed as critics, the founders of the site have until now been anonymous.

Today, however, founders Brandon Stell, George Smith, and Richard Smith unmasked themselves. They are joined on a board of directors by Boris Barbour and Gabor Brasnjo. Stell and Barbour are practicing scientists, while Brasnjo, who trained as a scientist, works as an attorney. Here’s the whole statement, followed by a Q&A with Stell: Continue reading PubPeer founders reveal themselves, create foundation

“Our manuscript unintentionally failed to meet academic and publication standards”

homeHeaderTitleImage_en_US

Authors of a 2014 review paper about the use of “as needed” medications by people with mental health diagnoses are retracting it, but we’re scratching our heads as to why.

The retraction appears in “The experiences of mental health professionals’ and patients’ use of pro re nata (PRN) medication in acute adult mental health care settings: a systematic review protocol of qualitative evidence,” published by The JBI Database of Systematic Reviews and Implementation Reports.

From the abstract of the paper:

Pro re nata is a Latin phrase meaning “for an unforseen need or contingency”…The authors of the systematic review found that although the practice of using “as required” medication is common there is no good evidence of whether this is the best way of helping people to be less agitated when compared to being given a regular dose of medication.

We’re not entirely sure what went wrong here. This is the full contents of the note:

Continue reading “Our manuscript unintentionally failed to meet academic and publication standards”

Yes, many psychology findings may be “too good to be true” – now what?

scienceToday, Science published the first results from a massive reproducibility project, in which more than 250 psychology researchers tried to replicate the results of 100 papers published in three psychology journals. Despite working with the original authors and using original materials, only 36% of the studies produced statistically significant results, and more than 80% of the studies reported a stronger effect size in the original study than in the replication. To the authors, however, this is not a sign of failure – rather, it tells us that science is working as it should:

Continue reading Yes, many psychology findings may be “too good to be true” – now what?